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Background: Tuberculosis is an infectious disease that continues to cause considerable morbidity and mortality
globally. Only 65% of patients worldwide are currently diagnosed. Contact investigation is a strategy that aims to
increase case detection and reduce transmission of tuberculosis, yet there is little evidence to show its effectiveness.
Methods/Design: We will conduct a cluster randomized controlled trial of contact investigation within the national
tuberculosis control program of Vietnam. Household contacts of patients with smear-positive pulmonary
tuberculosis will be invited to attend district tuberculosis units for symptom screening, examination, and chest
radiography on four occasions over a two-year period. The primary endpoint is clinically confirmed tuberculosis
among contacts during the 24 months of follow-up, ascertained using capture-recapture analysis. Microbiologically
proven tuberculosis and treatment completion rates among contacts diagnosed with tuberculosis will be secondary
endpoints. The incremental cost-effectiveness ratio will be estimated. The study will have 80% power to detect a
50% increase in the primary endpoint in the active intervention arm compared with the control arm. The study will
include 8,829 contacts in each of the active screening and control groups, within 70 districts in 8 provinces in
Vietnam, in both rural and urban settings.
Discussion: The effectiveness of contact investigation as a tool for improved tuberculosis case finding has not
been established. This cluster randomized trial will provide valuable operational information for national
tuberculosis programs in high-prevalence countries, in order to select the most cost-effective strategies to improve
tuberculosis case detection.
Trial registration: The ACT2 study has been registered with the Australian New Zealand Clinical Trials Registry
(ACTRN12610000600044).
Keywords: Contact tracing, Mycobacterium tuberculosis, Public health, Pulmonary tuberculosis, Screening,
TuberculosisBackground
Tuberculosis (TB) is an airborne infectious disease that
affects almost nine million people each year, mainly in
resource-limited settings [1]. The predominant global
strategy for identifying people with TB is ‘passive case
detection’, which relies upon a diagnosis of TB being
made in symptomatic patients presenting to healthcare
facilities for evaluation [2]. This approach is predicated* Correspondence: greg.fox@sydney.edu.au
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reproduction in any medium, provided the orupon the assumption that most patients will be symp-
tomatic. However, despite the widespread adoption of
this approach in high-prevalence countries, only 65% (63
to 68%) of the estimated total number of patients with
TB are diagnosed each year [3]. Those patients who are
not diagnosed are not treated, and are therefore at risk
of transmitting the infection to others. If the Stop TB
Partnership’s goal of global TB elimination by 2050 is to
be realized [4,5], new evidence-based strategies for en-
hancing case detection are urgently needed.. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Recent prevalence surveys in countries with a persist-
ently high prevalence of TB have found that a substan-
tial proportion of disease is not detected by conventional
passive case-finding strategies [6-8]. Strategies that in-
crease the proportion of cases that are detected may
interrupt ongoing transmission of M. tuberculosis, and
reduce the prevalence of TB over time [9,10]. Case de-
tection strategies that target high-risk populations and
are integrated with national TB control programs [11]
are most likely to be feasible and sustainable.
Contacts of patients with TB are known to have a high
risk of developing the disease, particularly in the five
years after exposure. A recent meta-analysis of studies
including almost 900,000 contacts showed that 3.1% (95%
confidence interval (CI), 2.2 to 4.4%) of contacts in studies
from resource-limited settings and 1.4% (95% CI, 1.1 to
1.8%) of contacts in studies from high-income countries
had co-prevalent TB [12]. In Vietnam, our previously
reported cohort study of active case finding in tuberculosis
(ACT1) found that among 545 household contacts, 0.7%
had co-prevalent disease [13]. Consequently, contacts are
a potentially high-yield population to screen for disease.
Close contacts of TB patients are also identified relatively
easily by TB control programs, which can build upon their
existing therapeutic relationship with the TB patient. For
these reasons, contact investigation, defined as the evalu-
ation of contacts of known TB patients for disease or in-
fection is potentially a worthwhile adjunct to an effective
TB control program in resource-limited settings.
Although contact investigation has been standard prac-
tice in most high-income countries for many years [14-17],
it has been much less commonplace in resource-limited
settings. Contact investigation policies in these settings
have generally focused on specific high-risk contacts, such
as children [18,19] and people living with HIV [20]. Recent
World Health Organization (WHO) guidelines for TB
contact investigation recommended the intervention be
extended to close contacts in settings where adequate re-
sources are available [21]. However, the expert panel ac-
knowledged that the quality of the available evidence for
the practice was very poor, according to GRADE criteria
[21]. Although many published studies report a high yield
among contacts, few assess the effectiveness compared
with standard passive case finding [22]. There have been
few randomized controlled trials of household contact in-
vestigation published to date [23,24].
Strategies for enhanced case detection in high-
prevalence settings must be feasible and cost-effective,
so that they are appropriate and affordable in the local
context. It is important that countries considering
implementing contact investigation have a high rate of
DOTS coverage and consistently high treatment com-
pletion rates, so that additional cases identified byenhanced case detection are likely to be treated success-
fully [25,26]. In order to be informative to health policy
makers, this study is designed so that the intervention
that is being evaluated can be implemented and scaled
up within the busy and resource-limited environment of
the Vietnamese healthcare system.
The research context
Vietnam is a middle-income country that is ranked elev-
enth in TB burden among the high-prevalence countries.
A national survey in 2006 estimated that the prevalence of
TB was 307 bacteriologically proven cases per 100,000
adults (95% CI, 249 to 366 per 100,000 persons aged 15
and over) [7]. Despite consistently achieving WHO targets
for treatment completion rates since 1998, annual case
notifications have not yet declined. Based on data from
the prevalence survey and routine reporting, the WHO es-
timates that only 56% (95% CI, 44 to 73%) of all cases are
diagnosed [1]. These data suggest that the Vietnamese Na-
tional Tuberculosis Program (NTP), which oversees the
majority of TB control in the country, may need to con-
sider new approaches to identify disease in the population.
The Active Case Finding of Tuberculosis (ACT2)
study is a cluster randomized controlled trial of contact
investigation that is conducted by staff of the NTP, based
at local district health facilities, and integrated within
the management structure of the NTP.
Hypothesis and aims
The hypothesis of this study is that, in countries that are
highly endemic for TB, targeted active case finding among
household contacts will result in more contacts being di-
agnosed with TB than will standard passive case finding
alone.
The primary aim of the study is to determine if house-
hold contact investigation is effective, by determining
whether it increases the overall yield of active TB diag-
nosed among household contacts of patients with smear-
positive TB compared with usual passive case detection.
There are two secondary aims. The first is to estimate the
cost effectiveness of this intervention by measuring the in-
cremental cost-effectiveness ratio. The second is to deter-
mine the feasibility of implementing contact investigation
within the NTP in a range of settings in Vietnam, includ-
ing urban and rural environments. The screening strategy
proposed in this study will be operationally nested within
the NTP.
Methods/Design
This is a cluster randomized controlled trial with two
arms comparing standard passive case detection with
household contact investigation in eight provinces in
Vietnam. In the active intervention clusters, household
contacts of patients with TB will be assessed for the
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ment comprises clinical evaluation, chest radiography
and, in TB suspects, microbiological testing of sputum.
Inclusion and exclusion criteria
All patients aged 15 years or over with pulmonary TB
and at least one sputum sample positive for acid-fast ba-
cilli on direct smear microscopy will be eligible to enter
the study. Patients are excluded if they have no eligible
household contacts.
Household contacts of any age are eligible for inclu-
sion if they lived in the same dwelling as the index pa-
tient during the two months prior to the diagnosis of the
index patient. Pregnant women are eligible for inclusion,
but women known to be pregnant are not offered a
chest radiograph.
Study endpoints
The following endpoints are being measured in all con-
tacts (in both groups). The primary endpoint is the pro-
portion of contacts with clinically diagnosed TB. This
will be ascertained based on the results of screening (in
the active screening districts) and routine notifications
to the NTP (in the active screening and control dis-
tricts). Secondary endpoints, as indirect measures of
study feasibility, are: (a) the weighted proportion of con-
tacts with microbiologically proven TB (defined as either
smear or culture positive TB), smear-positive TB and
extrapulmonary TB; (b) cost effectiveness, determined
by calculating the direct and indirect costs for each add-
itional case diagnosed; and (c) the proportion of eligible
contacts enrolling in the study, and the proportion of
contacts participating in scheduled follow-up.
Description of intervention
Recruitment of index cases
Index cases with smear-positive pulmonary TB and their
contacts are identified in both active and control study
districts. The study intervention is only implemented for
contacts in the active intervention districts.
Consecutive patients with smear-positive pulmonary
TB, who live in the study districts, are identified by TB
staff working within district hospitals or district tubercu-
losis units. Those who agree to participate are given a
participant information statement and asked to sign a
written consent form.
Recruitment of contacts
Contacts are identified using a screening questionnaire
completed in consultation with the index case. Household
contacts include all members of the household occupied
by the index case, including children and infants, who
were present during the period of recent infectivity, that
is, two months up to the time of diagnosis. Householdcontacts are approached by the index patient in their
family and given information explaining the study. Con-
tacts are invited by the patient to enroll in the study at a
district clinic.
Active intervention
All contacts in the active intervention districts will be
evaluated at the time they are first identified, and then 6,
12, and 24 months post-exposure. The procedures will
be free of charge to the participants. On each occasion,
the assessment will include a symptom questionnaire,
physical examination, and chest X-ray. Contacts will
have a chest X-ray at a local clinic or nearby private
radiology service. X-ray films will be read by local clin-
ical staff for routine clinical action and then be trans-
ferred to a central location for standardized re-reading
by provincial level staff.
Contacts will be defined as having possible TB if they
have: (a) cough lasting for two weeks, (b) sputum for
two weeks, (c) any hemoptysis, or (d) an abnormal chest
X-ray meeting the criteria for possible TB. Contacts
meeting one or more of these criteria will be asked to
submit two spontaneous sputum specimens collected on
consecutive days for acid-fast bacilli (AFB) examination.
Two direct smear examinations and one culture test will
be undertaken in the Provincial Hospital laboratory. For
children younger than five years, the diagnosis of TB will
be made on clinical and radiological grounds, in accord-
ance with local policy at the time of commencement of
the study. Treatment of active disease will be according
to the policies of the NTP. An experienced clinician in
each province will be available to advise district staff re-
garding the diagnosis of childhood TB and the investiga-
tion of suspected extrapulmonary disease.
Control districts
Contacts enrolled in control districts, will be given gen-
eral information about the typical symptoms of TB and
advised to report to the district hospital or TB unit if
they develop these symptoms. During the study period,
self-referring contacts with TB, who are participating in
the study, will have two sputum specimens transferred
to the reference laboratory for culture, in addition to any
routine diagnostic procedures. This will allow compari-
son of rates of culture-confirmed TB between active and
control districts. Contacts diagnosed with TB in both the
control and active intervention groups will receive stand-
ard treatment for TB through the NTP.
Selection of study districts
The study will be conducted in 70 districts within eight
provinces. These provinces have been selected to include
four provinces in the south (Ho Chi Minh City, Can
Tho City, and the rural provinces of An Giang and Tien
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inces from the central area (Da Nang Province and the
rural province of Binh Dinh), and two provinces from
the north (Hanoi City and the semi-rural province of
Vinh Phuc). This geographic and urban-rural stratifica-
tion is important because the incidence of TB increases
from the north to the south within Vietnam [7]. There are
also substantial differences in lifestyle and infrastructure
between rural and urban areas. Hence, the selection of this
diverse range of sites will increase the generalizability of
the study findings.
Randomization
Among the 97 districts within these eight provinces, 70
have been randomly selected for participation in the trial.
These districts were selected with a probability propor-
tional to their population size. The initially selected dis-
tricts will enter a run-in period, prior to randomization,
during which time they will be required to recruit two pa-
tients and six contacts and to demonstrate that they have
the necessary resources to conduct the study. If districts
fail or withdraw during this pre-randomization run-in
period, they will be replaced by the next randomly se-
lected district.
We will randomly allocate districts to the active inter-
vention or control group using the minimization method
with predefined randomization lists [27]. The minimization
criterion will be province, to ensure balance of intervention
and control districts within each province. District size will
not be taken into account in the randomization process.
Randomization will be performed by a person who is not
otherwise engaged in the project, and is blinded to the
identity of districts.
Sample size calculation
Based on an earlier meta-analysis, we estimated that the
prevalence of confirmed active TB in close contacts of
smear-positive cases would be 2.3% [28]. In the 2006 to
2007 National Prevalence Survey, approximately 50% of
prevalent cases of TB did not report typical symptoms
of the disease, suggesting that a substantial proportion
of patients with prevalent disease are not diagnosed by
routine passive case detection within the NTP. We esti-
mate that screening with the combination of X-ray and
symptoms will identify at least 75% of prevalent cases of
active pulmonary TB. This represents an increase in case
detection rate of 50% above that expected for passive case
finding alone. To have 80% power to detect an effect of
this size, we would need 3,313 contacts in each group
(6,626 in total), without accounting for clustering [29].
The sample size was then adjusted for the clustered
design of the study. The first level of clustering is at the
level of the index case. We estimated that, on average,
each index case would identify four close contacts whowould consent to participate. Assuming that the intraclass
correlation coefficient within households is 0.1, the design
effect at this level will be 1.3. The second level of cluster-
ing is at the level of the districts. There were 152 cases of
smear-positive pulmonary TB per district in 11 represen-
tative provinces in 2007. Assuming that 70% of smear-
positive cases consent to participate in the study, there
will be 106 index cases. If we assume an intraclass correl-
ation coefficient for index cases within districts of 0.01,
the design effect at this level will be 2.05. Hence, we an-
ticipate an overall design effect of 2.67.
On this basis, we estimate that we need to recruit a
total of 3,338 index cases and 8,829 contacts (of 2,207
index cases) in each group. Based on our assumptions,
this would require us to approach all available patients
diagnosed with smear-positive pulmonary TB in 21 dis-
tricts in each group: 42 districts in total. To ensure that
we have a conservative sample size calculation, we will
recruit all eligible and consenting index cases and their
contacts from 70 districts.
Specific quarterly recruitment targets will be set for
each district, based upon the number of notified cases of
smear-positive TB during the most recent year for which
data were available, as a way of enabling districts to track
their progress during the study.
Analysis of effectiveness
The effectiveness of the active case finding in contacts
will be assessed by comparing the case detection rate be-
tween contacts of index cases in the active intervention
and control districts. There are two levels of clustering
in the selection of contacts: the district in which the
contact lives and the index case with whom he or she
was in contact. To account for these two levels of clus-
tering, we will undertake a mixed model analysis in
which districts and index cases within districts are ran-
dom effects and active versus control status is the fixed
effect. The measure of effect will be relative risk, esti-
mated using a log link and binomial error distribution.
In this primary analysis, there will be no adjustment for
baseline characteristics. However, in a subsidiary analysis
we will examine the impact of baseline characteristics of
the districts, including geographical characteristics and
baseline case notification rate, and individuals, including
age and sex, on the risk of disease by testing these char-
acteristics as potential effect modifiers.
Primary and secondary endpoints and stratification
The primary endpoint will be the weighted proportion
of contacts with clinically diagnosed TB in screening and
control districts during the two-year follow-up period of
the study. Secondary endpoints will include the weighted
proportion of contacts with microbiologically proven TB,
smear-positive TB, and extrapulmonary TB. We will also
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treatment. Stratum specific weighted prevalence rates of
clinically diagnosed and microbiologically proven TB will
be determined for region and rurality.
Analysis of cost effectiveness
Direct costs of diagnosis and treatment will be deter-
mined based upon questionnaires for staff and patients
at provincial and district level healthcare facilities. Indir-
ect costs will be determined based upon detailed ques-
tionnaires for patients, contacts, and staff. Costs will be
classified into one of two categories: those related to the
identification of new TB suspects among the contacts of
TB cases and those related to investigation and manage-
ment of TB suspects. The former are costs that are
unique to this intervention. The latter costs are already
met by the NTP but these will be increased by the inter-
vention because there will be more TB suspects.
The incremental cost-effectiveness ratio will be calcu-
lated as the difference in total cost for TB control mea-
sures between the active and control districts divided by
the difference in the number of cases detected.
Data collection and management
Data will be recorded on paper forms at district clinics
and provincial hospitals. Each district will submit a
monthly report on the recruitment index cases and con-
tacts and the occurrence of study endpoints. These data
will be entered within one month of collection into an
online database. Written data and chest radiographs
from each district will be digitally photographed, and the
images transferred to the National Lung Hospital for
electronic data entry and quality control. Data will be
entered using a custom-designed, internet-based data-
base, and monthly data checking and quality control will
be performed at a central level. District staff will be pro-
vided regularly with a list of additional information re-
quired. A record of the proportion of children diagnosed
with TB by chest X-ray will be compiled every three
months, to ensure that the proportion of children receiv-
ing tuberculosis treatment does not exceed that recog-
nized in the published literature.
Quality control
The technical quality of chest radiographs will be
assessed at the National Lung Hospital by examining all
radiographs labeled as abnormal and a random sample
of all other radiographs. All radiographs read at the dis-
trict level will be re-read at the provincial level, and the
district staff will be informed of discrepancies. Quality
control of laboratory testing will be performed according
to the routine protocols of the NTP, including structured
quarterly monitoring visits by staff from the National
Lung Hospital.Evaluation and monitoring
Members of the project research staff will conduct mon-
itoring visits to each province every quarter, and to each
district at least once each year. Provincial TB control
staff will also conduct quarterly monitoring visits to each
district in conjunction with routine monitoring for the
NTP. Monitoring visits will include checking participant
consent forms, confirmation that enrolled index patients
have been included in the district notification registry,
checking research forms for completeness, and compli-
ance with study protocols.
To verify subject consent, randomly selected contacts
from each district will be telephoned by study staff to
confirm they have consented to participate in the re-
search. Irregularities in recruitment will be followed up
by provincial staff and reported back to research staff.
Ethical issues
Ethical approval
The protocol, patient information sheet, and patient con-
sent form have been approved by the Human Research
Ethics Committee at the University of Sydney, the Scien-
tific Committee of the Vietnam Ministry of Health and
the Scientific Committee of the Vietnam National Lung
Hospital.
Informed consent
Subjects may only enter the study if written informed
consent is obtained. Written consent by parents will be
required for children under 15 years of age. The
healthcare worker enrolling the subject will be respon-
sible for obtaining written informed consent and con-
sent forms will be checked during regular monitoring
visits by research staff.
Withdrawal from the study
Research participants may voluntarily withdraw from the
study for any reason. If they withdraw then there is to
be no adverse impact upon the treatment of the TB pa-
tient within the NTP.
Confidentiality
A unique study code will be assigned to each research
subject, and used to identify radiographs and laboratory
specimens. Written records will be stored securely in
the district clinics and provincial hospitals or at the Na-
tional Lung Hospital. The online database and electronic
records will be password protected.
Discussion
Investigation of TB contacts may be a valuable next step
in controlling TB in countries that have achieved consist-
ently good treatment outcomes under directly observed
therapy (DOT). Household contacts of TB patients are
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there is not yet sufficient evidence to determine whether
active case finding in contacts will detect more cases than
passive case finding alone [22]. Furthermore, there are no
data on the cost effectiveness of contact investigation in
Vietnam. Consequently, a randomized controlled trial is
required to assess the effectiveness and cost effectiveness
of contact investigation in a high-prevalence setting.
This study will be limited to contacts of smear-positive
patients because smear-positive index patients are more
likely to transmit TB [30] and the prevalence of TB
among their contacts is high [12]. Since prolonged ex-
posure to an infectious patient confers a higher risk of
disease [31,32], household contacts form an ideal popu-
lation to target for screening.
There is limited evidence quantifying the extent to
which disease among household contacts is actually
caused by transmission within the household. Several
studies in high-prevalence settings have shown that be-
tween 17% and 46% of households where two or more
patients have TB share identical molecular fingerprints
[33-35]. This suggests that much transmission may occur
outside of the household. However, these studies may have
underestimated household transmission, as they only in-
cluded patients diagnosed through passive case finding.
As a result, they may have missed household contacts with
minimal symptoms. Nonetheless, household contacts will
also share other environmental and genetic risk factors for
disease with the index patient. Contacts are also relatively
accessible to TB treatment programs that are already
treating the index patient.
Importantly, this research is closely integrated with the
existing national TB control program. This integration will
ensure that experienced workers within the NTP assess
contacts, and that affected contacts can readily be treated.
This research design is essential to the general applicability
of the research and its relevance to future policy decision-
making and scale-up. The study is a form of operational
research, which is a systematic approach to developing
evidence for an intervention that is useful to policy makers
[36]. Operational research is a cornerstone of the WHO’s
Stop TB strategy, since high quality trial evidence is recog-
nized to be essential if limited health resources are to be
directed most appropriately [37]. By integrating research
within the Vietnamese NTP, the outcomes of this study
will be relevant and generalizable beyond the research set-
ting. A limitation of our approach is that we will not be
administering isoniazid preventive therapy (IPT) to child
contacts. This approach is recommended by international
guidelines [38]. At the time that recruitment to this study
commenced, IPT was not the standard of care for child
contacts in Vietnam. Therefore, based on the local policies
at the time of study commencement, clinical and radio-
logical evaluation will be the cornerstone of our evaluationof children. National Guidelines were revised in 2012 to
recommend IPT for child contacts of patients with TB,
with implementation over the following year. Recruitment
to this study was due to end by mid-2013, hence it was
not possible to change practice for IPT for contacts in the
context of this study. Future contact tracing investigations
in adults in Vietnam should include prescription of IPT
for child contacts. By performing serial chest radiographs
for contacts in the screening group until 24 months, we
will be able to detect and treat a high proportion of disease
that develops in this time.
Although randomized controlled trials have often been
considered overly ambitious in resource-limited settings,
our study will combine the rigor of this design with the
practicalities of routine TB control. It will also contrib-
ute to the capacity of local staff to conduct research, and
support the supervision of the research within the struc-
tures of the NTP. By implementing the study within
eight provinces, we will also learn valuable lessons about
the practical challenges encountered in contact investi-
gation throughout the country that will inform future
policy development.
Therefore, this cluster randomized controlled trial will
provide an important evidence base to assist policy
makers in Vietnam and comparable countries in their
decisions about the programmatic implementation of ac-
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